| 000 | 01444 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517025514.0 | ||
| 264 | 0 | _c20160504 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1873-5576 | ||
| 024 | 7 |
_a10.2174/1568009615666150416122422 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHan, Xiaohong | |
| 245 | 0 | 0 |
_aAn Integrative Analysis of the Putative Gefitinib-resistance Related Genes in a Lung Cancer Cell Line Model System. _h[electronic resource] |
| 260 |
_bCurrent cancer drug targets _c2015 |
||
| 300 |
_a423-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aChromosome Mapping _xmethods |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 | _aGefitinib |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 |
_aQuinazolines _xpharmacology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aLiu, Manjiao | |
| 700 | 1 | _aWang, Shuai | |
| 700 | 1 | _aLv, Guanting | |
| 700 | 1 | _aMa, Li | |
| 700 | 1 | _aZeng, Changqing | |
| 700 | 1 | _aShi, Yuankai | |
| 773 | 0 |
_tCurrent cancer drug targets _gvol. 15 _gno. 5 _gp. 423-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1568009615666150416122422 _zAvailable from publisher's website |
| 999 |
_c24808051 _d24808051 |
||